ORIC
ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.38 / 10
Outperform
With technical parameters scoring 6.38/10, the profile indicates favorable technical configuration. Encouraging developments in RSI Overbought and MACD Death Cross are counterbalanced by Long Lower Shadow. Technical outlook: cautiously optimistic.
Analysis Checks(2/3)
Long Lower Shadow
Score3.93/10
Win Rate51.92%
Hist. Signals52
Avg Return1.29%
Score3.93/10
Win Rate51.92%
Hist. Signals52
Avg Return1.29%
MACD Death Cross
Score7.8/10
Win Rate66.67%
Hist. Signals9
Avg Return5.25%
Score7.8/10
Win Rate66.67%
Hist. Signals9
Avg Return5.25%
RSI Overbought
Score7.41/10
Win Rate62.50%
Hist. Signals16
Avg Return4.05%
Score7.41/10
Win Rate62.50%
Hist. Signals16
Avg Return4.05%
Long Lower Shadow
Score3.93/10
Win Rate51.92%
Hist. Signals52
Avg Return1.29%
Score3.93/10
Win Rate51.92%
Hist. Signals52
Avg Return1.29%
RSI Overbought
Score7.41/10
Win Rate62.50%
Hist. Signals16
Avg Return4.05%
Score7.41/10
Win Rate62.50%
Hist. Signals16
Avg Return4.05%
MACD Death Cross
Score7.8/10
Win Rate66.67%
Hist. Signals9
Avg Return5.25%
Score7.8/10
Win Rate66.67%
Hist. Signals9
Avg Return5.25%
Technical Analysis of ORIC?
- ORIC presents a Outperform setup with a Technical Score of 6.38/10. Key technical indicators highlight an RSI of 48.57 and a MACD of -0.34, with the trend anchored by the 50-Day SMA at 10.06. Traders should monitor key support at 9.49 and resistance at 10.63.
